Tuesday, July 16, 2013
A little late but...healthy living post is here!
So my blogging goal is to post about physical and spiritual fitness on Mondays, which is going okay so far. I have a special treat for today since I'm a day late. Here's an important message from Dr. Mercola. But first here's a quick update on upcoming events: I'll be at the Robin Hood Festival this Friday 5pm to ??, and Saturday 9am to 8pm? Sunday August 4th I'll be at loyal local with some awesome new Vancouver Author friends. More details to follow soon. Okay, so this is probably controversial and will get me yelled at, but I have had knee jerk resistance to the idea of a cancer vaccine since I first heard of it. Now some research is being done to clarify things. Link to article. "There are currently two HPV vaccines on the market, but if there was any regard for sound scientific evidence, neither would be promoted as heavily as they are. The first, Gardasil, was licensed by the US Food and Drug Administration (FDA) in 2006. It is now recommended as a routine vaccination for girls and women between the ages of 9-26 in the US. On October 25, 2011, the CDC’s Advisory Committee on Immunization Practices also voted to recommend giving the HPV vaccine to males between the ages of 11 and 21. The second HPV vaccine, Cervarix, was licensed in 2009. Most recently, an oncology dietitian pointed out significant discrepancies2 in a new HPV vaccine effectiveness study published in the Journal of Infectious Diseases3, which evaluated data from the National Health and Nutrition Examination Surveys (NHANES), 2003-2006 and 2007-2010. The study pointed out that HPV vaccine uptake among young girls in the US has been low but concluded that: “Within four years of vaccine introduction, the vaccine-type HPV prevalence decreased among females aged 14–19 years despite low vaccine uptake. The estimated vaccine effectiveness was high.” Story at-a-glance An oncology dietitian has pointed out significant discrepancies in a new HPV vaccine effectiveness study that claims the vaccine’s effectiveness is “high” Recent reductions in HPV infection prevalence among young women in the US cannot be said to be due to introduction of Gardasil vaccine in 2006 and use of HPV vaccines by pre-teen and teenage girls since then; the data clearly shows that unvaccinated girls had the best outcome In 2007-2010, HPV prevalence dropped 27.3 percent in the unvaccinated girls, but only declined by 5.8 percent in the vaccinated group. In four out of five different measures, the unvaccinated girls had a lower incidence of HPV According to Merck’s own research before Gardasil was licensed, if you've been exposed to HPV strains 16 or 18 prior to receiving Gardasil vaccine, you could increase your risk of precancerous lesions by 44.6 percent. Judicial Watch has received previously withheld documents from the DDHS, which reveal that the National Vaccine Injury Compensation Program has awarded $5,877,710 to 49 victims for harm resulting from the HPV vaccine